Showing 1–7 of 7 results
-
Reviews |
-
Research | | Open
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade
- Nicolas Jacquelot
- , Takahiro Yamazaki
- , Maria P. Roberti
- , Connie P. M. Duong
- , Miles C. Andrews
- , Loic Verlingue
- , Gladys Ferrere
- , Sonia Becharef
- , Marie Vétizou
- , Romain Daillère
- , Meriem Messaoudene
- , David P. Enot
- , Gautier Stoll
- , Stefano Ugel
- , Ilaria Marigo
- , Shin Foong Ngiow
- , Aurélien Marabelle
- , Armelle Prevost-Blondel
- , Pierre-Olivier Gaudreau
- , Vancheswaran Gopalakrishnan
- , Alexander M. Eggermont
- , Paule Opolon
- , Christophe Klein
- , Gabriele Madonna
- , Paolo A. Ascierto
- , Antje Sucker
- , Dirk Schadendorf
- , Mark J. Smyth
- , Jean-Charles Soria
- , Guido Kroemer
- , Vincenzo Bronte
- , Jennifer Wargo
- & Laurence Zitvogel
-
Editorial |
-
Amendments and Corrections |
-
Reviews |
-
-
Reviews |
Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination
- Celine Boutros
- , Ahmad Tarhini
- , Emilie Routier
- , Olivier Lambotte
- , Francois Leroy Ladurie
- , Franck Carbonnel
- , Hassane Izzeddine
- , Aurelien Marabelle
- , Stephane Champiat
- , Armandine Berdelou
- , Emilie Lanoy
- , Matthieu Texier
- , Cristina Libenciuc
- , Alexander M. M. Eggermont
- , Jean-Charles Soria
- , Christine Mateus
- & Caroline Robert
